| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |